A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Clinical trial NCT03512353 · TERMINATED
Trial details
- NCT number
- NCT03512353
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-05
- Primary completion
- 2020-01-16
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.